Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Biomarkers in Medicine|August 16, 2014
IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinomaIvonne Nel, Hideo A Baba, Frank Weber, et al.Journal of Surgical Oncology|January 31, 2009
Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resectionAndreas-Claudius Hoffmann, Jan Brabender, Ralf Metzger, et al.Translational Oncology|August 3, 2013
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinomaIvonne Nel, Hideo A Baba, Judith Ertle, et al.Journal of Cancer Research and Clinical Oncology|March 5, 2009
Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcomeAndreas-Claudius Hoffmann, Daniel Vallböhmer, Klaus Prenzel, et al.Neoplasia (New York, N.Y.)|August 7, 2010
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapyAndreas-Claudius Hoffmann, Peter Wild, Christina Leicht, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 29, 2016
Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tagsDominik Andre Megger, Kristin Rosowski, Maike Ahrens, et al.Journal of Proteome Research|December 3, 2015
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular CarcinomaWael Naboulsi, Dominik A Megger, Thilo Bracht, et al.Biochimica Et Biophysica Acta|March 19, 2013
A practical data processing workflow for multi-OMICS projectsMichael Kohl, Dominik A Megger, Martin Trippler, et al.Molecular & Cellular Proteomics : MCP|March 7, 2013
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics studyDominik A Megger, Thilo Bracht, Michael Kohl, et al.Neoplasia (New York, N.Y.)|July 2, 2008
High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGFAndreas-Claudius Hoffmann, Ryutaro Mori, Daniel Vallbohmer, et al.Pageof 3